|
?:authorAffiliation
|
-
[\'Department of Emergency Medicine / Division of Toxicology, Brigham & Women\'s Hospital / Harvard Medical School, 10 Vining St, Boston, MA, 02155, USA. terickson@bwh.harvard.edu.\', \'Division of Medical Toxicology, Department of Emergency Medicine, Mass General Brigham, Boston, USA. terickson@bwh.harvard.edu.\', \'Harvard Humanitarian Institute, Cambridge, MA, USA. terickson@bwh.harvard.edu.\', \'Biobot Analytics, Inc., Cambridge, MA, USA.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.\', \'Campus for Research Excellence and Technological Enterprise (CREATE), Singapore, Singapore.\', \'Broad Institute of MIT and Harvard, Cambridge, MA, USA.\', \'Department of Emergency Medicine / Division of Toxicology, Brigham & Women\'s Hospital / Harvard Medical School, 10 Vining St, Boston, MA, 02155, USA.\', \'Division of Medical Toxicology, Department of Emergency Medicine, Mass General Brigham, Boston, USA.\', \'The Fenway Institute, Boston, MA, USA.\', \'The Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}